Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Clin Psychopharmacol. 2016 Jun;36(3):213–221. doi: 10.1097/JCP.0000000000000488

Fig. 3.

Fig. 3

Subject-rated and cardiovascular measures. Mean peak participant ratings for Performance Impaired from the Drug-Effect Questionnaire, the Sedative scale from the Adjective Rating Scale (top panels) and mean peak systolic blood pressure and heart rate (bottom panels) following administration of methamphetamine and the four maintenance conditions. Other details are as in Fig. 2.